Lung Cancers Completed Phase 1 / 2 Trials for Docetaxel (DB01248)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00390429Docetaxel and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsTreatment
NCT00405951Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)in Combination With Docetaxel for the Treatment of Non-Small Cell Lung CancerTreatment
NCT00073866Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung CancerTreatment
NCT00062270Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung CancerTreatment
NCT00003037Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung CancerTreatment
NCT00003103Chemotherapy in Treating Patients With Solid TumorsTreatment